中国糖尿病杂志
中國糖尿病雜誌
중국당뇨병잡지
CHINESE JOURNAL OF DIABETES
2008年
5期
297-298
,共2页
王茜%沈备%覃又文%刘超
王茜%瀋備%覃又文%劉超
왕천%침비%담우문%류초
糖尿病%2型%初诊%β细胞功能%胰岛素抵抗
糖尿病%2型%初診%β細胞功能%胰島素牴抗
당뇨병%2형%초진%β세포공능%이도소저항
Diabetes mellitus,type 2,newly diagnosed%β-cell function% Insulin resistance% Blood glucose
使用甘精胰岛素联合二甲双胍或格列美脲联合二甲双胍进行3个月短期强化治疗,两组患者的FPG和HbA1c均获得良好控制,第一时相和第二时相胰岛素和C肽分泌量明显增加、胰岛素抵抗显著改善.
使用甘精胰島素聯閤二甲雙胍或格列美脲聯閤二甲雙胍進行3箇月短期彊化治療,兩組患者的FPG和HbA1c均穫得良好控製,第一時相和第二時相胰島素和C肽分泌量明顯增加、胰島素牴抗顯著改善.
사용감정이도소연합이갑쌍고혹격렬미뇨연합이갑쌍고진행3개월단기강화치료,량조환자적FPG화HbA1c균획득량호공제,제일시상화제이시상이도소화C태분비량명현증가、이도소저항현저개선.
36 newly diagnosd type 2 diabetic patients were treated with insulin glargine plus metformin or glimepiride plus metformin for 3 months.Excellent control of FBG and HbA1c was achieved in both groups after 3 months’ intensive treatment.The β-cell hypofunction and insulin resistance were improved significantly in both groups. 更多还原
